ANZUP Below the Belt Initiative

ANZUP Cancer Trials Group is a leading clinical research organization in Australia and New Zealand focused on improving outcomes for patients with "below the belt" cancers, including prostate, kidney, bladder, testicular, and penile cancers. The "Below the Belt Initiative" serves as the organization's primary fundraising and community engagement arm, supporting the development of innovative clinical trials that might not otherwise receive funding. ANZUP operates as a multidisciplinary cooperative group, bringing together over 2,000 clinicians, researchers, and healthcare professionals to design and conduct high-impact studies. Their portfolio includes landmark trials such as ENZAMET and TheraP, which have significantly influenced global standards of care in urogenital oncology. By bridging the gap between laboratory research and clinical practice, ANZUP aims to provide patients with access to the latest therapeutic advancements.